药剂师对糖尿病患者抑郁症查和管理的贡献:系统性审查
Mai I Al-Hawamdeh1,2, Fatma Al Raisi3,4, Rana Moustafa Al-Aladawi5,6
1University of Jordan, Amman, 11942, Jordan.
International journal of clinical pharmacy
|November 28, 2025
概括
药剂师有效选和管理糖尿病患者的抑郁症,改善治疗的开始和坚持. 需要标准化的护理模型来持续改善临床结果.
科学领域:
- 临床药房 临床药房
- 公共卫生 公共卫生
- 慢性疾病管理 慢性疾病管理
背景情况:
- 抑郁症影响全球5%的成年人,而糖尿病等慢性疾病的负担更高.
- 糖尿病患者抑郁症的诊断不足和管理不足带来了重大的临床和经济挑战.
- 药剂师对于通过查和药物管理来管理慢性疾病,包括抑郁症至关重要.
研究的目的:
- 系统地审查和综合有关药剂师在查和管理糖尿病患者抑郁症方面的作用的证据.
- 评估药剂师干预措施对临床结果和生活质量的影响.
- 评估药剂师作为单一提供者或多学科团队的一部分的贡献.
主要方法:
- 在Medline,CINAHL和IPA数据库 (更新于2025年3月) 进行系统的文献搜索.
- 纳入关于药剂师在糖尿病患者抑郁症查和治疗方面的贡献的研究,无论设计或日期如何.
- 基于Donabedian模型 (结构,过程,结果) 的数据提取和使用混合方法评估工具进行质量评估.
主要成果:
- 十项研究符合纳入标准,详细介绍了药剂师在查中的角色 (4),药物治疗管理 (6),远程医疗 (2) 和共享预约 (1).
- 药剂师的干预积极影响了抑郁症查,治疗开始和药物坚持.
- 一些干预措施在改善HbA1c或抑郁症状方面取得了有限的成功;障碍包括医生的反应和缺乏结构化的护理.
结论:
- 药剂师干预表明对糖尿病和抑郁症患者产生积极影响,展示了服务适应性.
- 标准化的护理模型和一致的结果报告是优化干预措施的必要条件.
- 需要进一步的研究来解决障碍,并加强临床参数的改进.
更多相关视频
04:29Vagus Nerve Stimulation As an Adjunctive Neurostimulation Tool in Treatment-resistant Depression
Published on: January 7, 2019
29.4K
08:15Network Pharmacology and Validation of the Antidepressant Mechanisms of Qiangzhifang in a Chronic Restraint Stress-induced Depression Rat Model
Published on: June 6, 2025
491
相关概念视频
Diabetes: Management and Pharmacotherapy
835
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
835
Antidepressant Drugs: MAOIs and Other Agents
761
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
761
Depression: Overview
735
Depression is a prevalent mental illness marked by persistent sadness and lack of interest in previously enjoyable activities. It can take several forms, including major depression, persistent depressive disorder, and bipolar I and II disorders. Symptoms range from emotional changes like chronic worry to physical changes like sleep disturbances and suicidal thoughts. From a neurobiological perspective, depression is believed to be triggered by abnormalities in the brain's prefrontal cortex,...
735
Antidepressant Drugs: Overview
1.3K
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
1.3K
Depressive Disorders: MDD and Dysthymia
547
Depressive disorders are a group of mental health conditions characterized by pervasive feelings of sadness, diminished pleasure in life, and a significant impact on daily functioning. These conditions are most prevalent in individuals during their 30s and affect women at twice the rate of men. Contrary to popular belief, younger individuals are generally more susceptible to these disorders than older adults. Two key types of depressive disorders include Major Depressive Disorder (MDD) and...
547
Psychosis: Goals of Pharmacotherapy
434
Antipsychotic drugs are a crucial treatment method for acute and chronic psychoses, bipolar illness, and behavioral disorders. The selection of these drugs depends on several factors, including the state of the disease, clinical judgment, possible drug interactions, and the patient's sensitivity to adverse effects. In immediate scenarios, such as delirium and dementia, short-term treatment with low doses of high-potency typical or atypical agents can effectively manage symptom exacerbation.
434
